Acessibilidade / Reportar erro

Perianal Psoriasis as the First Manifestation of the Disease

Abstract

Introduction

Inverse psoriasis affects the skin of flexural areas, such as the groin, axillae, umbilicus, intergluteal fold, and external genitalia.

Clinical Case

We herein report the case of a man who presented with anal pruritus and, upon physical examination, a perianal dermatosis was found, which was characterized by erythematous plaques, with fine scaling. The case was initially managed with zinc oxide, and when no improvement was observed, we decided to take an incisional biopsy, which indicated histological changes suggestive of psoriasiform dermatitis.

Discussion

Inverse psoriasis affects 3% to 7% of patients with psoriasis, and it manifests with erythematous plaques without the classic scaling appearance. The skin in these areas is susceptible to maceration, irritation, and ulceration, which alter the classic clinical picture. It may present with typical lesions or, less frequently, in isolation in the anogenital region. In the anogenital presentation only, the diagnosis should be made by biopsy, looking for the classic histopathological features of psoriasis. As for the first-line treatment, low- or medium-potency topical steroids are used for short periods of time; the second-line treatment is with emollients and tar-based products; and the third-line treatment uses an immunomodulator.

Conclusion

This presentation is infrequent, and it requires a high index of suspicion for the diagnosis, always supported by biopsies, in search of the classic histopathological features of psoriasis.

Keywords
perianal psoriasis; inverse psoriasis; perianal pruritus

Introduction

Psoriasis is a chronic inflammatory dermatosis that affects approximately 1% to 3% of the population, and it manifests with erythematous plaques with scaling. It commonly affects the elbows, knees, scalp, and, less frequently, the skin of the face, palms, soles; when it affects intertriginous regions (21–30%), it is known as “inverse psoriasis”, a rare form of presentation in flexural areas, such as the groin, axillae, umbilicus, intergluteal fold and external genitalia.

Clinical Case

We herein report the case of a 38-year-old male patient who presented to the clinic referring intense anal pruritus of sudden onset, for which he applied zinc oxide ointment by self-prescription.

The patient had no past medical history, he referred 3 to 4 bowel movements a day, had a score of 4 to 5 on the Bristol stool chart, without bleeding, with water intake around 1 L every day, and abundant intake of fats and dairy products. He reported a feeling of wetness around the anus during the day.

The physical examination revealed a dirty anus with perianal dermatosis limited to the anal verge, characterized by erythematous plaques, with fine scaling, extending towards the anal canal, moist and friable skin (Image 1). The rectal examination and anoscopy were normal.

Image 1
Perianal dermatosis characterized by erythematous plaques with fine scaling.

Topical treatment was administered with zinc oxide every 12 hours and changes in hygienic-dietary habits were suggested.

When the patient returned for a check-up after 3 weeks, he reported not having ingested irritants, fats, and drinking more than 2L of water per day. The physical examination revealed localized dermatosis of the perianal skin characterized by erythematous skin with fine scales. As there was no improvement with the treatment, we decided to take an incisional biopsy of the perineal skin, which indicated histological changes suggestive of psoriasiform dermatitis (Image 2).

Image 2
Stratified flat epithelium with connected interpapillary ridges, with intraepidermal inflammatory infiltrate, with formation of Munro microabscesses.

Upon detailed physical examination, the patient was found to have erythematous plaques with fine, pruritic scaling on the neck and ulnar fossae (Image 3).

Image 3
Erythematous plaques with fine, pruritic scaling on the neck (right) and ulnar fossae (left).

Discussion

Inverse psoriasis affects approximately 3% to 7% of patients with psoriasis, and it manifests with well-demarcated erythematous plaques without the classic appearance of desquamation and with a shiny aspect, which is why the diagnosis is often overlooked.

The characteristics of these specific skin areas, make them susceptible to maceration, irritation, and ulceration, and the absence of desquamation alters the classic clinical picture and causes symptoms such as pruritus, irritation, and pain. It may occur in conjunction with typical lesions in areas of extension or, less frequently, in isolation in the anogenital region in 2% to 5% of the patients.11 Dopytalska K, Sobolewski P, Błaszczak A, Szymańska E, Walecka I. Psoriasis in special localizations. Reumatologia 2018;56(06): 392–398, 22 Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb) 2012;2(01):1–9

Dermoscopy is an excellent diagnostic tool, especially when the disease presents in unusual anatomical areas, for it enables the finding of whitish scales with punctate vessels and tortuous capillaries with uniform distribution on an erythematous base. In the case of manifestations only in the anogenital region, the diagnosis should be made by biopsy, looking for the classic histopathological features of psoriasis, such as epidermal hyperplasia, acanthosis, hypogranulosis, hyperkeratosis, parakeratosis, and, in some cases, collections of Munro-Sabouraud neutrophils and Kogoj micropustules.22 Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb) 2012;2(01):1–9, 33 Kelly A, Ryan C. Genital psoriasis: impact on quality of life and treatment options. Am J Clin Dermatol 2019;20(05):639–646, 44 Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol 2019; 12:953–959

Treatment is challenging because there is greater absorption of steroids and alcohol in this area, which can lead to adverse reactions. Topical agents are recommended as firstline, with short course of steroids (two to four weeks). The second-line treatment consists of emollients and tarbased products, and the third-line treatment involves immunomodulators, which haveyielded good long-term results. In severe cases resistant to the topical treatment, the systemic treatment (with methotrexate, cyclosporine, biologic agents) can be considered; however, they often have a negative impact on quality of life and are not recommended in cases of isolated inverse psoriasis.11 Dopytalska K, Sobolewski P, Błaszczak A, Szymańska E, Walecka I. Psoriasis in special localizations. Reumatologia 2018;56(06): 392–398, 22 Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb) 2012;2(01):1–9

Conclusion

This presentation of psoriasis is quite infrequent, so it requires a high index of suspicion when encountering a patient with this type of manifestations and without a history suggestive of the diagnosis.We must relyon biopsies, looking for the classic histopathological characteristics of psoriasis, to reach the diagnosis and to be able to provide an adequate treatment.

References

  • 1
    Dopytalska K, Sobolewski P, Błaszczak A, Szymańska E, Walecka I. Psoriasis in special localizations. Reumatologia 2018;56(06): 392–398
  • 2
    Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb) 2012;2(01):1–9
  • 3
    Kelly A, Ryan C. Genital psoriasis: impact on quality of life and treatment options. Am J Clin Dermatol 2019;20(05):639–646
  • 4
    Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol 2019; 12:953–959

Publication Dates

  • Publication in this collection
    07 Apr 2023
  • Date of issue
    Oct-Dec 2022

History

  • Received
    21 Aug 2022
  • Accepted
    25 Oct 2022
Sociedade Brasileira de Coloproctologia Av. Marechal Câmara, 160/916, 20020-080 Rio de Janeiro/RJ Brasil, Tel.: (55 21) 2240-8927, Fax: (55 21) 2220-5803 - Rio de Janeiro - RJ - Brazil
E-mail: sbcp@sbcp.org.br